ADC Introduction Podcast

In this podcast, Creative Biolabs will introduce Antibody-Drug Conjugates (ADC), explaining the definition and mechanism of ADC, toxicity risk of ADC, and its features and prediction of future development. We hope to help you better understand what ADC is and its potential application. If you have any question, please contact us.

Please subscribe to follow the latest updates

What is ADC ?

  

A Brief Introduction of Antibody Drug Conjugate

  

Introduction Motivations for Next-Generation ADCs

  

Next Generation Payloads for ADCs

  

Combining ADCs with Immuno Oncology

  

Delivering More Payload -High DAR ADCs

  

Site-Specific Antibody-Drug Conjugates

  

Bispecific and Biparatopic Antibody Drug Conjugates

  

Targeting Drug Conjugates to the Tumor Microenvironment: Probody Drug Conjugates

  

Antibody Drug Conjugates Targeting the Tumor Microenvironment

  

Next Horizons-ADCs Beyond Oncology

  

• What is ADC ? 00:09:18
• A Brief Introduction of Antibody Drug Conjugate 00:10:30
• Introduction Motivations for Next-Generation ADCs 00:05:37
• Next Generation Payloads for ADCs 00:10:15
• Combining ADCs with Immuno Oncology 00:15:03
• Delivering More Payload-High DAR ADCs 00:11:26
• Site-Specific Antibody-Drug Conjugates 00:14:39
• Bispecific and Biparatopic Antibody Drug Conjugates 00:14:53
• Targeting Drug Conjugates to the Tumor Microenvironment: Probody Drug Conjugates 00:14:47
• Antibody Drug Conjugates Targeting the Tumor Microenvironment 00:11:18
• Next Horizons-ADCs Beyond Oncology 00:11:42